HostAPE vs RIF — price, size and safety, side by side
APE (Ethereum) vs RIF (Solana) — every figure is the freshest dated measurement we hold for that token, never a live-feed guess. Prices stamped 2026-09-27 / 2026-09-27.
APE vs RIF — normalized performance, 2026-09-27 to 2026-09-27T18:22:06
| APE | RIF | |
|---|---|---|
| Price | $0.1584 | $0.0002578 |
| Market cap | $158.40M | $252.54K |
| 24h volume | $90.78K | $4.53K |
| Liquidity | $270.24K | $190.72K |
| FDV | $158.40M | $252.54K |
| Holders | 189,466 | 25,209 |
| Safety grade | A | A |
Where they differ
- APE measures ~627× the market cap of RIF
- APE measures ~20× the 24h volume of RIF
- APE measures ~7.5× the holder count of RIF
What the data says
APE
APE passes the check that trips up most risky tokens — its contract controls. The contract cannot mint new supply, so the float can't be diluted, and the contract can't pause or block transfers, leaving you free to trade on your own terms. It's a reassuring starting point: 100/100 as of 2026-09-27, with the structural risks already off the table.
Looking at the market data, APE shows a $270.24K pool and a holder base of 189,466 as of 2026-09-27. Set the $270.24K pool against roughly $158.40M in market cap and the picture sharpens — depth is shallow for the size, so trades move the price more than the chart suggests and getting out cleanly takes care. The 189,466-wallet holder base is a genuine strength on top of that: distribution that broad is hard to manufacture, and it means no single wallet quietly owns the float. Reassuringly, the wallet that created APE holds under 5% of supply (<0.01%) as of 2026-09-27 — the deployer hasn't kept an oversized stake to unload.
RIF
Rifampicin — RIF — the flagship Pump.science longevity token: a DeSci experiment tokenizing a research program on a real compound (the antibiotic rifampicin, a candidate in longevity screening). Mint GJtJuWD9qYcCkrwMBmtY1tpapV1sKfB2zUv9Q4aqpump; the September 26, 2026 snapshot shows about $191 thousand of liquidity and roughly 25,209 holders.
RIF is the honest flagship of DeSci: a real experiment pipeline behind it — fly/worm longevity studies whose results stream publicly — which is a real thing, but the honest gap is that token price tracks narrative attention on the research, not a claim on any resulting IP or drug. If rifampicin's data disappoints, the token has no floor.
FAQ
Which is bigger, APE or RIF?
By tracked market cap: APE (Ethereum) measures $158.40M and RIF (Solana) measures $252.54K — dated snapshots, not a live feed.
Which is safer, APE or RIF?
On the contract checks we publish: APE (Ethereum) grades A and RIF (Solana) grades A. A grade is a structural check on the contract, not a promise about the asset.
How have APE and RIF performed over the shared window?
Between 2026-09-27 and 2026-09-27T18:22:06, the measured snapshots show APE at 0.00% and RIF at 0.00%.
More comparisons
USDUC vs APEMYX vs APEBERN vs APEAPE vs BTRRIF vs SOLTKALSHI vs RIFRIF vs UNIRIF vs BODEN
The grade column is the one CMC's compare page cannot print — our grade is computed from the contract itself (mint/freeze authority, liquidity, holder concentration). Changes are measured over the shared window stated on the chart, 2026-09-27→2026-09-27T18:22:06; a token with fewer measured points measures a shorter span inside it.
Figures are dated on-chain snapshots, not a live feed. Safety grades are structural checks — not investment advice. Free · no signup · a NexFlow product.